Pilot study of recombinant human alpha-interferon for chronic non-A, non-B hepatitis.

Abstract

Recombinant human alpha-interferon was administered to 15 patients with chronic non-A, non-B hepatitis as a part of a pilot study. Patients received injections of 2 million units per day of interferon three times weekly for 16 wk. The treatment schedule was completed in all but one, whose serum aminotransferase levels were continuously elevated during… (More)

Topics

  • Presentations referencing similar topics